Antipsychotic medications are critical to child and adolescent psychiatry, from the
stabilization of psychotic disorders like schizophrenia, bipolar disorder, and psychotic …

Depression is a common and severe mental disease that places a heavy burden on human
society, which can lead to decreased cognitive function, energy loss, insomnia, and even …

Schizophrenia (SCZ) is a severe mental disorder with high morbidity and lifetime disability
rates. Patients with SCZ have a higher risk of developing metabolic comorbidities such as …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in the world and one of the leading indications for liver transplantation. It is one of the many …

Probiotics have been suggested as alternatives to pharmacological drugs in the treatment of
a variety of medical problems, including obesity management, which is often linked to low …

Second-generation antipsychotics (SGAs) are the mainstay of treatment for schizophrenia
and other neuropsychiatric diseases but cause a high risk of disruption to lipid metabolism …

Background Olanzapine (OLZ) is one of the most effective atypical antipsychotics but is
associated with severe metabolic side effects, in which the gut microbiota plays an important …

Objectives We aimed to explore the interconnection between the weight-gain in
schizophrenia patients with atypical antipsychotic treatment and gut microbiome. Methods …

Olanzapine is one of the most effective medicines available for stabilizing schizophrenia
spectrum disorders. However, it has been reported to show the greatest propensity for …

Over the past century, we have witnessed an increase in life-expectancy due to public health
measures; however, we have also seen an increase in susceptibility to chronic disease and …